Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$12.35 - $19.33 $7,842 - $12,274
635 Added 2.94%
22,219 $294,000
Q4 2023

Feb 14, 2024

BUY
$12.87 - $19.09 $6,576 - $9,754
511 Added 2.42%
21,584 $408,000
Q3 2023

Nov 16, 2023

SELL
$15.0 - $22.17 $15,435 - $22,812
-1,029 Reduced 4.66%
21,073 $317,000
Q2 2023

Aug 11, 2023

SELL
$21.6 - $30.69 $27,799 - $39,498
-1,287 Reduced 5.5%
22,102 $477,000
Q1 2023

May 15, 2023

SELL
$23.07 - $32.77 $8,166 - $11,600
-354 Reduced 1.49%
23,389 $657,000
Q4 2022

Jan 31, 2023

BUY
$25.29 - $35.48 $10,267 - $14,404
406 Added 1.74%
23,743 $600,000
Q3 2022

Nov 14, 2022

SELL
$24.0 - $33.42 $7,248 - $10,092
-302 Reduced 1.28%
23,337 $672,000
Q2 2022

Aug 12, 2022

BUY
$24.78 - $33.36 $585,774 - $788,597
23,639 New
23,639 $599,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Ironwood Investment Management LLC Portfolio

Follow Ironwood Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Management LLC with notifications on news.